Glaucoma: An Open-Window to Neurodegeneration and Neuroprotection

EPIDEMIOLOGY AND CLINICAL ASSESSMENT OF THE DISEASE1. Epidemiology of primary glaucoma: prevalence, incidence, and blinding effects C. Cedrone, R. Mancino, A. Cerulli, M. Cesareo and C. Nucci (Italy)2. Predictive models to estimate the risk of glaucoma development and progression F.A. Medeiros and R.N. Weinreb (USA)3. Intraocular pressure and central corneal thickness G. Manni, F. Oddone, V. Parisi, A. Tosto and M. Centofanti (Italy)4. Angle-closure: risk factors, diagnosis and treatment N. Amerasinghe and T. Aung (Singapore)5. Early diagnosis in glaucoma D.F. Garway-Heath (UK, Italy)6. Monitoring glaucoma progression P. Brusini (Italy)ANATOMICAL AND FUNCTIONAL MONITORING7. Standard automated perimetry and algorithms for monitoring glaucoma progressions G.L. Scuderi, M. Cesareo, A. Perdicchi and S.M. Recupero (Italy)8. Short-wavelength automated perimetry and frequency-doubling technology perimetry in glaucoma P. Fogagnolo, L. Rossetti, S. Ranno, A. Ferreras and N. Orzalesi (Italy, Spain)9. Scanning laser polarimetry and confocal scanning laser ophthalmoscopy: technical notes on their use in glaucoma F. Ferreri, P. Aragona and G. Ferreri (Italy)10. The role of OCT in glaucoma management (Italy)11. Functional laser Doppler flowmetry of the optic nerve: physiological aspects and clinical applications C.E. Riva and B. Falsini (Italy)12. Advances in neuroimaging of the visual pathways and their use in glaucoma F.G. Garaci, V. Cozzolino, C. Nucci, F. Gaudiello, A. Ludovici, T. Lupattelli, R. Floris and G. Simonetti (Italy)CURRENT THERAPY13. Primary open angle glaucoma: an overview on medical therapy M. Vetrugno, F. Cantatore, G. Ruggeri, P. Ferreri, A. Montepara, A. Quinto and C. Sborgia (Italy)14. The treatment of normal tension glaucoma P.V. Desai and J. Caprioli (USA)15. The management of exfoliative glaucoma R. Rich (USA)16. Laser therapies for glaucoma: new frontiers G.L. Scuderi and N. Pasquale (Italy)17. Modulation of wound healing during and after glaucoma surgery S. Georgoulas, A. Dahlmann-Noor, S. Brocchini and P.-T. Khaw (UK)18. Surgical alternative to trabeculectomy R.G. Carassa (Italy)19. Modern aqueous shunt implantation ¡§C future challenges K. Barton and D.K. Heuer (London, UK and Milwaukee, USA)EXPERIMENTAL APPROACHES TO MODEL DISEASE20. Model systems for experimental studies: retinal ganglion cells in culture E. Goodyear, and L.A. Levin (Canada)21. Rat models for glaucoma research J.C. Morrison, E. Johnson and W.O. Cepurna (USA)22. Mouse genetic models: an ideal system for understanding glaucomatous neurodegeneration and neuroprotection R. Howell, R.T. Libby and S.W.M. John (USA)23. Clinical trials in neuroprotection S.M. Whitcup (USA)NEUROPROTECTION: NEW VISTAS IN PATHOPHYSIOLOGY24. Pathogenesis of ganglion cells in glaucoma and neuroprotection: Focus on ganglion cell axonal mitochondria N.N. Osborne (UK)25. Astrocytes in glaucomatous optic neuropathy M.R. Hernandez, H. Miao and T. Lukas (USA)26. Glaucoma as a neuropathy amenable to neuroprotection and immune manipulation M. Schwartz and A. London (Israel)27. Oxidative stress and glaucoma. Injury in the anterior segment of the eye S.C. Sacca and A. Izzotti (Italy)28. TNF-alpha signalling in glaucomatous neurodegeneration G. Tezel (USA)29. Involvement of the Bcl2 gene family in the signalling and control of retinal ganglion cell death R.W. Nickells, S.J. Semaan and C.L. Schlamp (USA)30. Assessment of neuroprotection in the retina with DARC L.Guo and M.F. Cordeiro (UK)31. Potential roles of (endo)cannabinoids in the treatment of glaucoma: from intraocular pressure control to neuroprotection C. Nucci, M. Bari, A. Spano, M.T. Corasaniti,, G. Bagetta, M. Maccarrone and L.A. Morrone (Italy)32. Glaucoma of the brain: a disease model for the study of transsynaptic neural degeneration Y.